| 000 | 01760 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515132608.0 | ||
| 264 | 0 | _c20081201 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1386-6532 | ||
| 024 | 7 |
_a10.1016/j.jcv.2008.06.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuesnel-Vallières, Mathieu | |
| 245 | 0 | 0 |
_aHCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1. _h[electronic resource] |
| 260 |
_bJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology _cOct 2008 |
||
| 300 |
_a236-40 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEvolution, Molecular |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 |
_aHepacivirus _xclassification |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfectious Disease Transmission, Vertical |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLemay, Mireille | |
| 700 | 1 | _aLapointe, Normand | |
| 700 | 1 | _aMartin, Steven R | |
| 700 | 1 | _aSoudeyns, Hugo | |
| 773 | 0 |
_tJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology _gvol. 43 _gno. 2 _gp. 236-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcv.2008.06.019 _zAvailable from publisher's website |
| 999 |
_c18180669 _d18180669 |
||